☆ 4.3 Letter

Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Add to Collection

Journal

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Volume 40, Issue 3, Pages 664-665

Publisher

CLINICAL & EXPER RHEUMATOLOGY

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.